1. Impact of human leukocyte antigen mismatch on outcomes after unrelated bone marrow transplantation in paediatric patients: A retrospective analysis by the JSTCT HLA working group.
- Author
-
Kato, Itaru, Sakaguchi, Hirotoshi, Kato, Shunichi, Sato, Maho, Noguchi, Maiko, Yoshida, Nao, Koh, Katsuyoshi, Koike, Takashi, Yanagimachi, Masakatsu, Kato, Keisuke, Takahashi, Yoshiyuki, Fujita, Naoto, Sato, Atsushi, Hashii, Yoshiko, Tabuchi, Ken, Atsuta, Yoshiko, Morishima, Satoko, and Kanda, Junya
- Subjects
BONE marrow transplantation ,HLA histocompatibility antigens ,CHILD patients ,RETROSPECTIVE studies ,HISTOCOMPATIBILITY class I antigens - Abstract
Summary: The impact of human leukocyte antigen (HLA) mismatching at the HLA‐A, ‐B, ‐C, and ‐DRB1 loci after unrelated bone marrow transplantation in paediatric patients with haematological malignancies has not been fully examined. Here, we analysed patients with haematological malignancies (all aged ≤15 years; n = 1330) who underwent a first unrelated bone marrow transplantation between 1993 and 2017 in Japan. The results show that although an HLA mismatch was significantly associated with a low relapse rate, it was also associated with higher non‐relapse mortality. There was a significant association between HLA mismatch and low overall survival. Locus mismatch analysis revealed that, as in adults, an HLA‐C mismatch had a significant negative impact on survival; however, in paediatric patients, an HLA‐DRB1 mismatch did not have a negative impact, although these HLA mismatch effects are weakened in recent cases. Taken together, the results suggest that an HLA‐matched donor should be the first candidate for paediatric patients; however, for patients without a matched sibling or matched unrelated donor, we can select an unrelated donor with a mismatch at HLA‐DRB1 if available. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF